The Joint Corp. (JYNT)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	168	159	142	203	947	369
Market Cap Growth	-1.78%	12.33%	-30.20%	-78.55%	156.78%	64.79%
Enterprise Value	156	148	150	217	948	369
Last Close Price	11.50	10.63	9.61	13.98	65.69	26.26
PE Ratio	-	-	-	324.12	125.16	28.00
Forward PE	28.68	92.44	77.69	69.90	206.38	71.61
PS Ratio	3.27	3.07	3.02	2.01	11.83	6.28
PB Ratio	8.84	8.88	5.72	6.23	31.24	17.45
P/TBV Ratio	8.84	8.89	5.73	15.46	46.22	27.04
P/FCF Ratio	98.76	19.35	14.65	87.91	138.13	45.94
P/OCF Ratio	60.60	16.92	9.66	24.74	68.39	32.97
PEG Ratio	-	3.20	3.20	2.80	8.26	3.58
EV/Sales Ratio	2.96	2.85	3.20	2.15	11.85	6.29
EV/EBITDA Ratio	-	642.67	95.48	27.57	94.13	45.13
EV/EBIT Ratio	-	-	505.80	175.51	154.13	67.81
EV/FCF Ratio	87.72	17.98	15.54	94.08	138.35	45.96
Debt / Equity Ratio	0.11	0.03	0.12	0.80	0.78	0.88
Debt / EBITDA Ratio	-	0.92	1.56	1.93	1.61	1.58
Debt / FCF Ratio	1.26	0.05	0.30	11.28	3.45	2.30
Asset Turnover	0.65	0.62	0.52	1.12	1.05	1.07
Quick Ratio	0.58	0.56	0.62	0.59	1.08	1.23
Current Ratio	1.59	1.46	1.32	0.76	1.25	1.37
Return on Equity (ROE)	-7.13%	-7.20%	-37.55%	1.99%	29.42%	98.09%
Return on Assets (ROA)	-1.06%	-0.84%	0.21%	0.86%	5.03%	6.21%
Return on Capital (ROIC)	-2.75%	-3.08%	0.43%	1.38%	8.22%	11.41%
Return on Capital Employed (ROCE)	-	-	0.60%	1.80%	9.40%	11.50%
Earnings Yield	-4.93%	-5.36%	-6.88%	0.31%	0.80%	3.57%
FCF Yield	1.01%	5.17%	6.83%	1.14%	0.72%	2.18%
Buyback Yield / Dilution	-1.82%	-3.13%	1.21%	0.45%	-2.42%	-0.80%

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q